| Biological Sciences | Lifetime | 15 | US 10 | 100.00 |
| Biological Sciences | 2021-2025 | 585 | US 128 | 99.38 |
| Immunology | Lifetime | 4 | US 2 | 99.99 |
| Molecular Biology | Lifetime | 69 | US 49 | 99.97 |
| Genetics | Lifetime | 338 | US 185 | 99.22 |
| Oncology | Lifetime | 419 | US 239 | 99.28 |
| Cancer Research | Lifetime | 194 | US 101 | 98.90 |
| Parasitology | Lifetime | 234 | US 100 | 97.37 |
| Medical Genetics | Lifetime | 883 | US 441 | 88.73 |
| Immunology | 2021-2025 | 56 | US 17 | 98.89 |
| Molecular Biology | 2021-2025 | 399 | US 108 | 98.04 |
| Immune Cell Function and Interaction | Lifetime | 1 | US 1 | 99.99 |
| T-cell and B-cell Immunology | Lifetime | 4 | US 3 | 99.98 |
| Immune Response and Inflammation | Lifetime | 6 | US 4 | 99.97 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 9 | US 6 | 99.88 |
| Immunotherapy and Immune Responses | Lifetime | 25 | US 18 | 99.94 |
| IL-33, ST2, and ILC Pathways | Lifetime | 7 | US 5 | 99.84 |
| Immune cells in cancer | Lifetime | 18 | US 7 | 99.86 |
| NF-κB Signaling Pathways | Lifetime | 6 | US 3 | 99.90 |
| Inflammasome and immune disorders | Lifetime | 11 | US 5 | 99.89 |
| Diabetes and associated disorders | Lifetime | 30 | US 18 | 99.70 |
| Cell death mechanisms and regulation | Lifetime | 21 | US 10 | 99.77 |
| interferon and immune responses | Lifetime | 37 | US 23 | 99.66 |
| RNA modifications and cancer | Lifetime | 213 | US 119 | 99.44 |
| CAR-T cell therapy research | Lifetime | 192 | US 122 | 99.32 |
| Cancer-related gene regulation | Lifetime | 143 | US 76 | 99.00 |
| Melanoma and MAPK Pathways | Lifetime | 51 | US 26 | 99.38 |
| Viral Infections and Vectors | Lifetime | 231 | US 119 | 99.12 |
| Vector-borne infectious diseases | Lifetime | 129 | US 74 | 98.77 |
| Signaling Pathways in Disease | Lifetime | 103 | US 60 | 98.55 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 294 | US 138 | 98.57 |
| Phagocytosis and Immune Regulation | Lifetime | 86 | US 34 | 98.06 |
| Cancer-related molecular mechanisms research | Lifetime | 679 | US 179 | 98.09 |
| TGF-β signaling in diseases | Lifetime | 97 | US 52 | 97.90 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 156 | US 84 | 97.78 |
| Autophagy in Disease and Therapy | Lifetime | 313 | US 118 | 97.80 |
| Pediatric health and respiratory diseases | Lifetime | 276 | US 108 | 98.19 |
| Pancreatic function and diabetes | Lifetime | 701 | US 297 | 98.10 |
| Gut microbiota and health | Lifetime | 743 | US 242 | 97.69 |
| Cell Adhesion Molecules Research | Lifetime | 779 | US 382 | 97.77 |
| DNA and Nucleic Acid Chemistry | Lifetime | 813 | US 425 | 97.28 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 560 | US 147 | 95.88 |
| RNA regulation and disease | Lifetime | 804 | US 354 | 94.26 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 741 | US 325 | 94.47 |
| Xenotransplantation and immune response | Lifetime | 239 | US 112 | 94.03 |
| Chemokine receptors and signaling | Lifetime | 550 | US 213 | 93.29 |
| Heat shock proteins research | Lifetime | 967 | US 400 | 92.09 |
| Protein Tyrosine Phosphatases | Lifetime | 585 | US 223 | 89.94 |
| Macrophage Migration Inhibitory Factor | Lifetime | 393 | US 176 | 89.49 |
| Dermatological diseases and infestations | Lifetime | 495 | US 211 | 89.00 |
| Kawasaki Disease and Coronary Complications | Lifetime | 919 | US 225 | 85.64 |
| Calcium signaling and nucleotide metabolism | Lifetime | 901 | US 307 | 85.22 |
| Inflammation biomarkers and pathways | Lifetime | 550 | US 149 | 77.35 |
| Whipple's Disease and Interleukins | Lifetime | 281 | US 86 | 78.06 |
| Immune Cell Function and Interaction | 2021-2025 | 107 | US 48 | 98.34 |
| RNA modifications and cancer | 2021-2025 | 239 | US 44 | 97.70 |
| Immune cells in cancer | 2021-2025 | 451 | US 95 | 92.54 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 126 | US 51 | 92.47 |
| interferon and immune responses | 2021-2025 | 310 | US 68 | 89.72 |
| Immune Response and Inflammation | 2021-2025 | 331 | US 84 | 86.41 |
| Inflammasome and immune disorders | 2021-2025 | 892 | US 151 | 81.93 |
| Cancer-related gene regulation | 2021-2025 | 922 | US 145 | 77.18 |